Will AmerisourceBergen continue to go out of hand in July?

This story will go over AmerisourceBergen. I will go over what exactly are AmerisourceBergen shareholders getting in July. Macroaxis considers AmerisourceBergen very steady given 1 month investment horizon. AmerisourceBergen secures Sharpe Ratio (or Efficiency) of 0.2773 which signifies that the organization had 0.2773% of return per unit of standard deviation over the last 1 month. Our philosophy in foreseeing volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty technical indicators for AmerisourceBergen Corporation which you can use to evaluate future volatility of the firm. Please makes use of AmerisourceBergen Risk Adjusted Performance of 0.01 and Mean Deviation of 1.34 to double-check if our risk estimates are consistent with your expectations.
Published over a year ago
View all stories for AmerisourceBergen | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Michael Smolkin

This firm has 4.64B in debt with debt to equity (D/E) ratio of 152.8 . This implies that the stock may be unable to create cash to meet all of its financial commitments. AmerisourceBergen dividends can provide a clue to current valuation of the stock. The firm one year expected dividend income is about $0.76 per share. Now, lets check AmerisourceBergen Market Capitalization. Based on recorded statements the market capitalization of AmerisourceBergen Corporation is about 16.34B. This is 26.26% higher than that of the Healthcare sector, and 68.48% higher than that of Medical Distribution industry, The Market Capitalization for all stocks is 14.13% higher than AmerisourceBergen.
What is the right price you would pay to acquire a share of AmerisourceBergen? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated. Please read more on our stock advisor page.

What is happening with AmerisourceBergen this year

Annual and quarterly reports issued by AmerisourceBergen are formal financial statements that are published yearly and quarterly and sent to AmerisourceBergen stockholders. The reports show and break down the current year's ongoing operations and discuss plans for the upcoming year. Annual reports have been a requirement from the Securities and Exchange Commission (SEC) for businesses owned by the public since 1934.
Companies such as AmerisourceBergen often view their annual report as an effective marketing tool to disseminate their perspective on company future earnings or innovations. With this in mind, many companies devote large sums of money to making their reports attractive and informative. In such instances, the annual report becomes a forum through which a company can communicate to the general public any number of topics that may or may not be directly related to the actual data published in the reports.

Breaking down AmerisourceBergen Further

The company has 4.64B in debt with debt to equity (D/E) ratio of 152.8 . This implies that AmerisourceBergen may be unable to create cash to meet all of its financial commitments. AmerisourceBergen has Current Ratio of 0.93 suggesting that it has not enough short term capital to pay financial commitments when the payables are due. The latest price spikes of AmerisourceBergen could raise concerns from investors as the firm closed today at a share price of 84.84 on 1003671.000 in volume. The company directors and management were quite successful positioning the firm components to exploit market volatility in July 2019. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.7053. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. AmerisourceBergen is selling at 85.05. That is 0.34 percent down. Opened at 85.05. AmerisourceBergen Shareholders Equity is decreasing over the last 4 years. Further, AmerisourceBergen Accumulated Other Comprehensive Income is increasing over the last 4 years.
 2015 2016 2017 2018 2019 (projected)
AmerisourceBergen Long Term Debt to Equity 1.82  1.83  1.54  1.38  1.32 
AmerisourceBergen Interest Coverage 10.91  7.30  8.26  9.50  11.50 
Taking everything into account, we believe that at this point AmerisourceBergen is very steady with low chance of distress within the next 2 years. Our present Buy/Hold/Sell recommendation on the company is Hold.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of AmerisourceBergen. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com